It has also been shown in preclinical studies that both GLP-1 receptor agonists and DPP-4 inhibitors exhibit cardioprotective effects in animal models of myocardial ischemia and ventricular insufficiency through incompletely characterized mechanisms. The gene discussed is DPP4; the disease is myocardial ischemia.